The TNFSF11 gene makes a signaling protein called RANKL, which tells certain cells when to clear away old bone so new bone can form normally. If it does not work, bone renewal is disrupted, so bones can become unusually dense and teeth may erupt late or not at all. This gene plays an important role in normal bone remodeling, which helps your skeleton grow, repair itself, and stay balanced over time. It also supports parts of the immune system.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or to regulate activities in the body. Some genes provide the directions for producing proteins, which are the cell components that do much of the work. Others are involved mainly in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes affect how your body grows and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this subject, you can find more in the LearnHub.
Overview
TNFSF11Gene function
What if the gene works
The TNFSF11 gene helps control bone renewal by making a signal that tells cells when to remove old bone. It also supports parts of immune system development.
Risk
What if the gene does not work
Reduced activity of the TNFSF11 gene can cause osteopetrosis, with unusually dense, fragile bones. Delayed tooth eruption and poor growth may occur, and milder or more severe variants can influence when symptoms appear and how marked they are.
Treatment
What does that mean for your treatment
In TNFSF11-related osteopetrosis, hematopoietic stem cell transplant usually does not correct the bone disease because the missing signal comes from bone-supporting cells rather than blood-forming cells. Treatment is mainly supportive, with care guided by bone, growth, dental, and nerve complications. Recombinant RANKL replacement is under study as a targeted treatment.
Conditions associated with TNFSF11
Gene function
What if the gene works
Your bones are constantly being renewed, and the TNFSF11 gene helps direct that process. It sends signals that allow old bone to be cleared away so new bone can take its place. TNFSF11 gene function also includes immune system communication, especially during early development of lymph tissues.
The TNFSF11 gene helps control normal bone remodeling, the lifelong process of removing older bone and replacing it with new bone. This keeps the skeleton strong and able to adapt to everyday stress.
Its protein gives a key signal to immature bone clearing cells, helping them grow into working osteoclasts. These cells break down worn bone in a controlled way so bone turnover stays balanced.
This gene also helps guide signals between certain immune cells. It supports the formation of some lymph tissues, which help the body organize immune responses.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TNFSF11 gene can lower RANKL levels, change its shape, or weaken its binding to its partner receptor, reducing the signal needed to form bone-resorbing cells. Milder changes may leave some signaling in place, while more severe variants can nearly abolish it. These changes show how variants in the TNFSF11 gene affect protein function and help explain why some people develop later or milder osteopetrosis, while others have earlier, more marked disease.
How variants are linked to conditions
Rare pathogenic variants in both copies of the TNFSF11 gene cause autosomal recessive osteopetrosis, a condition with unusually dense bones, delayed tooth eruption, and a tendency to fracture. In broader population studies, some common TNFSF11 variants have also been linked to differences in bone mineral density and fracture risk. These common findings describe shifts in risk, not a certain outcome.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widespread in the general population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well understood variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the TNFSF11 gene. Risk usually depends most on the exact gene change and family history, so anyone worried about personal risk should speak with a doctor or genetic counselor.
Inheritance of TNFSF11 variants
TNFSF11-related conditions follow an autosomal recessive inheritance pattern. In practical terms, a child usually inherits one TNFSF11 gene variant from each parent, and both parents are typically healthy carriers. When both parents carry a variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. Because the TNFSF11 inheritance pattern is recessive, mothers and fathers pass it on in the same way.
What does my TNFSF11 result mean for my family?
For families with a disease-causing TNFSF11 result linked to osteopetrosis, this is usually passed down in a recessive pattern. Parents are often healthy carriers, and brothers or sisters may also be carriers or, less often, may have the condition. Other relatives on both sides of the family can carry the same change.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the TNFSF11 gene, clinicians use genetic testing for TNFSF11 variants on a blood or saliva sample. The lab reads the gene’s DNA sequence and may also check for missing or extra pieces. Results can show whether a variant linked with a TNFSF11 related condition is present.
When should I consider getting a genetic test?
Consider TNFSF11 testing if a child has signs of a rare inherited bone condition, such as unusually dense bones on scans, repeated fractures, delayed tooth eruption, or ongoing low calcium, especially with a family history. It can also help clarify the cause when doctors suspect osteopetrosis or a similar bone condition.
A genetic result is only one part of your health story
Genetic test results can give useful insight, but how much they reveal varies with the condition and the kind of variant found. Over time, the way the body functions is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information provides context rather than certainty and makes most sense when considered with the rest of a person’s care. In other situations, a genetic finding can give a clear answer. For topics like medication response, these results may also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles some medicines and how strongly you respond to them. Small inherited differences may change how a drug is absorbed, broken down, moved through the body, or recognized at its target. That helps explain why the same treatment works well for one person, causes more side effects in another, or has little effect in someone else. These differences are common and are one part of the bigger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics focuses on how differences in genes affect the way people respond to medicines. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support treatment choices that are more informed and more individualized. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the TNFSF11 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or how well a treatment is working are best discussed with your doctor. Research on TNFSF11 has explored possible links with response to some bone-related treatments, but this has not become routine medical guidance.
History
The TNFSF11 gene entered medical research in the late 1990s, when several groups identified the same signaling protein through bone and immune system studies and gave it different names, including RANKL, ODF, and TRANCE. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped connect bone breakdown to a clear inherited pathway. Researchers soon showed that TNFSF11 was central to the formation and activity of osteoclasts, the cells that break down bone. Building on this early work, scientists uncovered more about the gene and linked rare TNFSF11 variants to inherited conditions affecting bone density. This history also shaped the development of newer treatments for bone loss by targeting the RANKL pathway.